Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs
- 15 July 2011
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 410 (4), 707-713
- https://doi.org/10.1016/j.bbrc.2011.04.133
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the proteinProceedings of the National Academy of Sciences of the United States of America, 2011
- Sulfated Glycosaminoglycans Accelerate Transthyretin Amyloidogenesis by Quaternary Structural ConversionBiochemistry, 2010
- A Substructure Combination Strategy To Create Potent and Selective Transthyretin Kinetic Stabilizers That Prevent Amyloidogenesis and CytotoxicityJournal of the American Chemical Society, 2009
- Chemoselective small molecules that covalently modify one lysine in a non-enzyme protein in plasmaNature Chemical Biology, 2009
- Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell cultureBiochemical and Biophysical Research Communications, 2008
- Toward Optimization of the Linker Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural StudiesJournal of Medicinal Chemistry, 2008
- Heart Transplantation for Homozygous Familial Transthyretin (TTR) V122I Cardiac AmyloidosisAmerican Journal of Transplantation, 2008
- Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicityProceedings of the National Academy of Sciences of the United States of America, 2008
- Cell based screening of inhibitors of transthyretin aggregationBiochemical and Biophysical Research Communications, 2006
- The systemic amyloidosesCurrent Opinion in Rheumatology, 2004